Michael Crowell

Title: Michael Crowell: Innovator in Microbial Management for Obesity

Introduction

Michael Crowell is an inventive mind based in Fountain Hills, AZ (US). He has made significant contributions to the field of microbial management, particularly in relation to obesity. His innovative approach focuses on managing intestinal microbial communities to reduce energy uptake in obese individuals.

Latest Patents

Michael Crowell holds a patent titled "Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities." This invention provides microbial compositions and methods aimed at reducing the concentration of short-chain fatty acids in the gut. By decreasing the availability of short-chain fatty acids, such as acetate, for absorption in the human gut, his invention offers a novel approach to managing obesity. The patent outlines various methods, including the use of probiotics, microbial electrolysis cells, prebiotics, and selective antibiotics to achieve this goal.

Career Highlights

Michael Crowell is affiliated with Arizona State University, where he continues to explore innovative solutions in the realm of microbial management. His work is pivotal in understanding how gut microbiota can influence obesity and energy uptake.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Bruce E. Rittmann and Rosa Krajmalnik-Brown. These partnerships have further enriched his research and contributed to advancements in the field.

Conclusion

Michael Crowell's innovative work in managing intestinal microbial communities represents a significant advancement in obesity research. His patent reflects a promising approach to reducing energy uptake and managing obesity through microbial interventions.